DrugCite
Search

VIBRAMYCIN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Vibramycin Adverse Events Reported to the FDA Over Time

How are Vibramycin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Vibramycin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Vibramycin is flagged as the suspect drug causing the adverse event.

Most Common Vibramycin Adverse Events Reported to the FDA

What are the most common Vibramycin adverse events reported to the FDA?

Nausea
162 (1.72%)
Vomiting
157 (1.67%)
Rash
149 (1.58%)
Headache
129 (1.37%)
Diarrhoea
118 (1.25%)
Drug Interaction
111 (1.18%)
Drug Hypersensitivity
102 (1.08%)
Dyspnoea
101 (1.07%)
Drug Ineffective
90 (.96%)
Pyrexia
90 (.96%)
Asthenia
85 (.9%)
Show More Show More
Pain
82 (.87%)
Malaise
79 (.84%)
Pruritus
78 (.83%)
Dizziness
72 (.76%)
Hypersensitivity
67 (.71%)
Chest Pain
63 (.67%)
Stevens-johnson Syndrome
63 (.67%)
Fatigue
58 (.62%)
Erythema
57 (.61%)
Renal Failure Acute
56 (.59%)
Paraesthesia
55 (.58%)
Abdominal Pain Upper
53 (.56%)
Photosensitivity Reaction
53 (.56%)
Drug Rash With Eosinophilia And Sys...
52 (.55%)
Oesophageal Ulcer
52 (.55%)
Confusional State
51 (.54%)
Urticaria
50 (.53%)
Oedema Peripheral
49 (.52%)
Renal Failure
49 (.52%)
Hypotension
48 (.51%)
Arthralgia
47 (.5%)
Abdominal Pain
44 (.47%)
Condition Aggravated
44 (.47%)
Dysphagia
44 (.47%)
Hypoglycaemia
44 (.47%)
Benign Intracranial Hypertension
42 (.45%)
Depression
42 (.45%)
Drug Exposure During Pregnancy
41 (.44%)
Cholestasis
39 (.41%)
Abdominal Discomfort
38 (.4%)
Liver Function Test Abnormal
38 (.4%)
Convulsion
37 (.39%)
Hypoaesthesia
37 (.39%)
Alanine Aminotransferase Increased
36 (.38%)
Blister
36 (.38%)
Cough
36 (.38%)
Muscle Spasms
36 (.38%)
Swollen Tongue
35 (.37%)
Weight Decreased
35 (.37%)
Dyspepsia
34 (.36%)
Feeling Abnormal
34 (.36%)
Tinnitus
34 (.36%)
Myalgia
33 (.35%)
Vision Blurred
32 (.34%)
Visual Impairment
32 (.34%)
Toxic Epidermal Necrolysis
31 (.33%)
Burning Sensation
30 (.32%)
Anxiety
29 (.31%)
Aspartate Aminotransferase Increase...
29 (.31%)
Chills
29 (.31%)
Dehydration
29 (.31%)
Dysgeusia
29 (.31%)
Pneumonia
29 (.31%)
Respiratory Failure
29 (.31%)
Decreased Appetite
28 (.3%)
Intracranial Pressure Increased
28 (.3%)
Jaundice
28 (.3%)
Renal Impairment
28 (.3%)
Haemoglobin Decreased
27 (.29%)
Oesophagitis
27 (.29%)
Somnolence
27 (.29%)
Disseminated Intravascular Coagulat...
26 (.28%)
Liver Disorder
26 (.28%)
Palpitations
26 (.28%)
Pancreatitis
26 (.28%)
Tremor
26 (.28%)
Interstitial Lung Disease
25 (.27%)
Pancreatitis Acute
25 (.27%)
Angioedema
24 (.25%)
Burn Oesophageal
24 (.25%)
Pain In Extremity
24 (.25%)
Gamma-glutamyltransferase Increased
23 (.24%)
Swelling Face
23 (.24%)
Alopecia
22 (.23%)
Candidiasis
22 (.23%)
Oropharyngeal Pain
22 (.23%)
Anaemia
21 (.22%)
Drug Intolerance
21 (.22%)
General Physical Health Deteriorati...
21 (.22%)
Hepatitis
21 (.22%)
Hyperhidrosis
21 (.22%)
Insomnia
21 (.22%)
Jarisch-herxheimer Reaction
21 (.22%)
Septic Shock
21 (.22%)
Tachycardia
21 (.22%)
Agitation
20 (.21%)
Amnesia
20 (.21%)
Blood Creatine Phosphokinase Increa...
20 (.21%)
Blood Pressure Increased
20 (.21%)
Dermatitis Exfoliative
20 (.21%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Vibramycin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Vibramycin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Vibramycin

What are the most common Vibramycin adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Vibramycin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Vibramycin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Vibramycin According to Those Reporting Adverse Events

Why are people taking Vibramycin, according to those reporting adverse events to the FDA?

Acne
439
Product Used For Unknown Indication
360
Drug Use For Unknown Indication
247
Infection
146
Rosacea
134
Lyme Disease
115
Show More Show More
Lower Respiratory Tract Infection
106
Sinusitis
92
Malaria Prophylaxis
78
Rash
68
Prophylaxis
66
Bronchitis
66
Pneumonia
55
Respiratory Tract Infection
48
Urinary Tract Infection
44
Antibiotic Therapy
43
Upper Respiratory Tract Infection
43
Staphylococcal Infection
39
Cellulitis
34
Ill-defined Disorder
33
Infection Prophylaxis
25
Cough
24
Vaginal Infection
23
Periodontal Disease
23
Scrub Typhus
22
Bacterial Infection
22
Chlamydial Infection
21
Arthropod Bite
20
Prostatitis
18
Sclerotherapy
18
Dermatitis
17
Pelvic Inflammatory Disease
17
Chronic Obstructive Pulmonary Disea...
17
Non-small Cell Lung Cancer
16
Periodontitis
16
Tooth Infection
15
Antibiotic Prophylaxis
15
Rheumatoid Arthritis
14
Skin Infection
14
Sepsis
14
Syphilis
14
Tenosynovitis
14
Borrelia Infection
13
Endometriosis
13
Device Related Infection
13
Pyrexia
13
Ear Infection
12
Brucellosis
12
Lung Infection
11
Eye Infection
11
Localised Infection
11

Drug Labels

LabelLabelerEffective
Vibramycin HyclatePfizer Laboratories Div Pfizer Inc25-MAY-11
Vibramycin CalciumPfizer Laboratories Div Pfizer Inc25-MAY-11
Vibra-tabsPfizer Laboratories Div Pfizer Inc25-MAY-11
Vibramycin MonohydratePfizer Laboratories Div Pfizer Inc25-MAY-11

Vibramycin Case Reports

What Vibramycin safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Vibramycin. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Vibramycin.